Previous antiplatelet treatment and mortality in patients with intracerebral hemorrhage [11]

Stroke

Volumn 38, Issue 3, 2007, Pages 863-

  Roquer, Jaume ^a  

^a HOSPITAL DEL MAR   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ANAMNESIS; BRAIN HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; LETTER; LOGISTIC REGRESSION ANALYSIS; MORTALITY; PRIORITY JOURNAL; RATING SCALE; RISK FACTOR; SCORING SYSTEM; STATISTICAL MODEL; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; CHEMICALLY INDUCED DISORDER; NOTE; TIME;

CEREBRAL HEMORRHAGE; HUMANS; PLATELET AGGREGATION INHIBITORS; TIME FACTORS;

EID: 33947509897     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000257315.72369.4e     Document Type: Letter

References (3)

1. Foerch C, Sitzer M, Steinmetz H, Neumann-Haefelin T; for the Arbeitsgruppe Schlaganfall Hessen. Pretreatment with antiplatelet agents is not independently associated with unfavorable outcome in intracerebral hemorrhage. Stroke. 2006;37:2165-2167.
2. Roquer J, Rodríguez Campello A, Gomis M. Ois A, Puente V, Munteis E. Previous antiplatelet therapy is an independent predictor of 30-day mortality after spontaneous supratentorial intracerebral haemorrhage. J Neurol. 2005;252:412-416.
3. Hemphill JC 3rd, Bonovich DC, Besmertis L, Manley GT, Johnston SC. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke. 2001;32:891-897.